Literature DB >> 27918832

The Effect of Ambient Titanium Dioxide Microparticle Exposure to the Ocular Surface on the Expression of Inflammatory Cytokines in the Eye and Cervical Lymph Nodes.

Youngsub Eom1, Jong Suk Song1, Hyun Kyu Lee1, Boram Kang1, Hyeon Chang Kim2, Hyung Keun Lee3, Hyo Myung Kim1.   

Abstract

Purpose: To investigate the ocular immune response following exposure to airborne titanium dioxide (TiO2) microparticles.
Methods: Rats in the TiO2-exposed group (n = 10) were exposed to TiO2 particles for 2 hours twice daily for 5 days, while the controls (n = 10) were not. Corneal staining score and tear lactic dehydrogenase (LDH) activity were measured to evaluate ocular surface damage, serum immunoglobulin (Ig) G and E were assayed by using enzyme-linked immunosorbent assay, and the size of cervical lymph nodes was measured. In addition, the expression of interleukin (IL)-4, IL-17, and interferon (IFN)-γ in the anterior segment of the eyeball and cervical lymph nodes was measured by immunohistochemistry, real-time reverse transcription-polymerase chain reaction (RT-PCR), and Western blot analysis.
Results: Median corneal staining score (3.0), tear LDH activity (0.24 optical density [OD]), and cervical lymph node size (36.9 mm2) were significantly higher in the TiO2-exposed group than in the control group (1.0, 0.13 OD, and 26.7 mm2, respectively). Serum IgG and IgE levels were found to be significantly elevated in the TiO2-exposed group (P = 0.021 and P = 0.021, respectively). Interleukin 4 expression was increased in the anterior segment of the eyeball and lymph nodes following TiO2 exposure, as measured by immunostaining, real-time RT-PCR, and Western blot. In addition, IL-17 and IFN-γ levels were also increased following TiO2 exposure compared to controls as measured by immunostaining. Conclusions: Exposure to airborne TiO2 induced ocular surface damage. The Type 2 helper T-cell pathway seems to play a dominant role in the ocular immune response following airborne TiO2 exposure.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27918832     DOI: 10.1167/iovs.16-19944

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Algorithmic intraocular lens power calculation formula selection by keratometry, anterior chamber depth and axial length.

Authors:  Jung Wan Kim; Youngsub Eom; Eun Gyu Yoon; Young Choi; Jong Suk Song; Ji Won Jeong; Seh Kwang Park; Hyo Myung Kim
Journal:  Acta Ophthalmol       Date:  2021-08-11       Impact factor: 3.988

2.  Potential Biomarkers and Drugs for Nanoparticle-Induced Cytotoxicity in the Retina: Based on Regulation of Inflammatory and Apoptotic Genes.

Authors:  Dongli Xie; Jianchen Hu; Tong Wu; Kangli Cao; Xiaogang Luo
Journal:  Int J Environ Res Public Health       Date:  2022-05-06       Impact factor: 4.614

3.  The Secretory Response of Rat Peritoneal Mast Cells on Exposure to Mineral Fibers.

Authors:  Violetta Borelli; Elisa Trevisan; Vita Francesca; Giuliano Zabucchi
Journal:  Int J Environ Res Public Health       Date:  2018-01-10       Impact factor: 3.390

4.  Exposure to Traffic-Related Particulate Matter 2.5 Triggers Th2-Dominant Ocular Immune Response in a Murine Model.

Authors:  Hyun Soo Lee; Sehyun Han; Jeong-Won Seo; Ki-Joon Jeon
Journal:  Int J Environ Res Public Health       Date:  2020-04-24       Impact factor: 3.390

5.  Comparison of cytotoxicity effects induced by four different types of nanoparticles in human corneal and conjunctival epithelial cells.

Authors:  Xiangzhe Li; Boram Kang; Youngsub Eom; Jingxiang Zhong; Hyung Keun Lee; Hyo Myung Kim; Jong Suk Song
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

6.  SIRT1 Protects Against Particulate Matter-Induced Oxidative Stress in Human Corneal and Conjunctival Epithelial Cells.

Authors:  Xiangzhe Li; Boram Kang; Youngsub Eom; Jingxiang Zhong; Hyung Keun Lee; Hyo Myung Kim; Jong Suk Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-09-01       Impact factor: 4.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.